| # | Drug | Count |
|---|---|---|
| 0 | DURVALUMAB | 16 |
| 1 | CARBOPLATIN | 2 |
| 2 | CLOPIDOGREL | 2 |
| 3 | CLOPIDOGREL BISULFATE | 2 |
| 4 | FLUOROURACIL | 2 |
| 5 | FLUOROURACIL CREAM, 0.5% | 2 |
| 6 | PEMBROLIZUMAB | 2 |
| 7 | PROPRANOLOL HYDROCHLORIDE | 2 |
| 8 | ROSUVASTATIN | 2 |
| 9 | ABEMACICLIB | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DURVALUMAB | 16 | 0.0007 |
| 1 | ABEMACICLIB | 1 | 0.0000 |
| 2 | RIBOCICLIB | 1 | 0.0000 |
| 3 | NEBIVOLOL HYDROCHLORIDE | 1 | 0.0000 |
| 4 | PROPRANOLOL HYDROCHLORIDE | 2 | 0.0000 |
| 5 | FLUOROURACIL CREAM, 0.5% | 2 | 0.0000 |
| 6 | FLUOROURACIL | 2 | 0.0000 |
| 7 | ZOLEDRONIC ACID | 1 | 0.0000 |
| 8 | ROSUVASTATIN | 2 | 0.0000 |
| 9 | LETROZOLE TABLETS | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Ligand-1 Blocker [EPC] | 16 | 0.0007 |
| 1 | P2Y12 Platelet Inhibitor [EPC] | 2 | 0.0000 |
| 2 | Aromatase Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Platinum-based Drug [EPC] | 2 | 0.0000 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 2 | 0.0000 |
| 5 | HMG-CoA Reductase Inhibitor [EPC] | 2 | 0.0000 |
| 6 | beta-Adrenergic Blocker [EPC] | 1 | 0.0000 |